Havranek, O
335  results:
Search for persons X
?
2

Ultrahypofractionated Stereotactic Radiation Therapy for Lo..:

Cvek, J. ; Knybel, L. ; Skacelikova, E....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E246 , 2016
 
?
3

C81 Is there an intermediate risk group of nonseminoma?:

Havránek, O. ; Hajek, J. ; Cvek, J...
European Urology Supplements.  12 (2013)  4 - p. e1189, C81 , 2013
 
?
4

84 Genomic rearrangements in BRCA1/2 and CHEK2 genes in Cze..:

Ticha, I. ; Stribrna, J. ; Soukupova, J....
European Journal of Cancer Supplements.  8 (2010)  5 - p. 22 , 2010
 
?
5

C84 LONG-TERM OUTCOMES OF PATIENTS TREATED FOR TESTICULAR C..:

Havranek, O. ; Krhut, J. ; Nemec, D....
European Urology Supplements.  9 (2010)  6 - p. 640 , 2010
 
?
6

85 Risk of non-Hodgkin lymphoma development in patients car..:

Havranek, O. ; Kleibl, Z. ; Soucek, P..
European Journal of Cancer Supplements.  8 (2010)  5 - p. 22 , 2010
 
?
7

C18 ACTIVATION OF BRAIN STRUCTURES DURING MICTURITION IN WO..:

Krhut, J. ; Holy, P. ; Tintera, J....
European Urology Supplements.  9 (2010)  6 - p. 624 , 2010
 
?
8

Anti-apoptotic MCL1 protein represents critical survival mo..:

Klanova, M ; Kazantsev, D ; Pokorna, E...
info:eu-repo/semantics/altIdentifier/doi/10.1158/1535-7163.MCT-21-0511.  , 2021
 
?
15

Initial rhythm and survival in refractory out-of-hospital c..:

Fingrova, Z ; Havranek, S ; Rob, D...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
1-15